75岁初级预防患者停用他汀的心血管影响:法国全国队列研究
调整基线和时变协变量后,停药与任何心血管事件住院风险增加33%相关(HR 1.33,95%CI 1.18-1.50)。
要点
- 75岁初级预防患者停用他汀与心血管事件住院风险增加33%相关。
- 冠脉事件风险增加更明显(HR 1.46,95%CI 1.21-1.75)。
- 该关联支持对老年初级预防患者继续他汀治疗需个体化评估。
核心结论
- 在75岁初级预防患者中,停用他汀与心血管事件住院风险增加33%相关(HR 1.33,95%CI 1.18-1.50)。
研究设计与样本
- 采用边际结构模型估计停用他汀与继续治疗的HR,调整基线和时变协变量(心血管药物使用、合并症和衰弱指标)。
主要发现
- 停用他汀与任何心血管事件住院的调整HR为1.33(95%CI 1.18-1.50)。
- 冠脉事件调整HR为1.46(95%CI 1.21-1.75),脑血管事件调整HR为1.26(95%CI 1.05-1.51),其他血管事件调整HR为1.02(95%CI 0.74-1.40)。
临床怎么用
- 对75岁初级预防患者,停用他汀前应评估心血管风险,避免不必要的停药。
- 临床决策需结合患者合并症、衰弱状态及偏好,个体化权衡继续他汀的获益与风险。
局限性
- 观察性设计不能排除残余混杂,需随机对照研究确认。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The role of statin therapy in primary prevention of cardiovascular disease in persons older than 75 years remains a subject of debate with little evidence to support or exclude the benefit of this treatment. We assessed the effect of statin discontinuation on cardiovascular outcomes in previously adherent 75-year-olds treated for primary prevention. METHODS AND RESULTS: A population-based cohort study using French national healthcare databases was performed, studying all subjects who turned 75 in 2012-14, with no history of cardiovascular disease and with a statin medication possession ratio ≥80% in each of the previous 2 years. Statin discontinuation was defined as three consecutive months without exposure. The outcome was hospital admission for cardiovascular event. The hazard ratio comparing statin discontinuation with continuation was estimated using a marginal structural model adjusting for both baseline and time-varying covariates (cardiovascular drug use, comorbidities, and frailty indicators). A total of 120 173 subjects were followed for an average of 2.4 years, of whom 17 204 (14.3%) discontinued statins and 5396 (4.5%) were admitted for a cardiovascular event. The adjusted hazard ratios for statin discontinuation were 1.33 [95% confidence interval (CI) 1.18-1.50] (any cardiovascular event), 1.46 (95% CI 1.21-1.75) (coronary event), 1.26 (95% CI 1.05-1.51) (cerebrovascular event), and 1.02 (95% CI 0.74-1.40) (other vascular event). CONCLUSION: Statin discontinuation was associated with a 33% increased risk of admission for cardiovascular event in 75-year-old primary prevention patients. Future studies, including randomized studies, are needed to confirm these findings and support updating and clarification of guidelines on the use of statins for primary prevention in the elderly.
引用
- Giral P, Neumann A, Weill A, et al. Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France. Eur Heart J. 2019. PMID: 31362307. doi:10.1093/eurheartj/ehz458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。